Navigation Links
Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi

A new study says that symptoms associated with ovarian cancer start much earlier before the diagnosis// is made and being alert to these symptoms could make a huge difference in the rapid treatment of the cancer. Ovarian cancer is more curable if detected early enough.

The study team led by Dr. Lloyd H. Smith from the University of California Davis Health System in Sacramento says that their observations 'provide objective evidence that patients with ovarian cancer, as a group, are distinguishable symptomatically from controls at least 6 months prior to diagnosis.'

The team monitored the pattern of appearance of the symptoms like abdominal bloating and pain, and the associated diagnostic tests in 1,900 with Ovarian cancer and 6,000 women with breast cancer, and 11,000 women without cancer. The team arrived at the conclusion that women with ovarian cancer were more likely to have 'target symptoms' like the abdominal pain and bloating around six months before the diagnosis was confirmed. The team also found that abdominal imaging and pelvic imaging with CA125 testing was common around 3 months before diagnosis, but the same was lacking 4 to 36 months prior to diagnosis. CA125 is a protein whose levels are increased in ovarian cancer. 'Our findings suggest that ovarian cancer could be diagnosed earlier in some patients whose diagnosis is currently delayed by at least 4 months, because physicians order abdominal imaging or perform gastrointestinal procedures before they order a test that is more likely to diagnose ovarian cancer, such as pelvic imaging and/or CA125,' the authors conclude. The details of the study are published in the October 1 issue of the journal Cancer.


'"/>




Page: 1

Related medicine news :

1. Ovarian cancer in relationship with Hormone therapy
2. Exercise lowers Risk of Ovarian Cancer
3. Gene Mutation Causes Ovarian Failure
4. Ovarian Cancer Screening Questioned
5. Thawed Ovarian Transplant
6. The Benefits Of Chemotherapy For Women With Ovarian Cancer
7. Progesterone Found To Increase Ovarian Cancer Risk
8. Developmental Origins of Polycystic Ovarian Syndrome
9. Polycystic Ovarian Syndrome(PCOS) linked to Diabetes
10. Ovarian cancer risk reduced by regular exercise
11. Genetic Profile To Predict Ovarian Cancer Prognosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology: